Phase II trial of first-line capecitabine plus cisplatin in patients with advanced/metastatic nasopharyngeal cancer (NPC)

被引：1
|
作者：
Chua, D.
Ng, W.
Yiu, H.
Seetalarom, K.
Kurnianda, J.
Sze, W.
Krishnan, G.
Shotelersuk, K.
Hong, R.
Forster, G.
机构：
[1] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[2] Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[4] Pramongkutklao Hosp, Bangkok, Thailand
[5] Sardjito Hosp, Yogyakarta, Indonesia
[6] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China
[7] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia
[8] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[9] Natl Taiwan Univ Hosp, Taipei, Taiwan
[10] Hoffmann La Roche, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6033
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
    Chua, Daniel T. T.
    Yiu, Harry Ho-Yin
    Seetalarom, Kasan
    Ng, Alice Wan-Ying
    Kurnianda, Johan
    Shotelersuk, Kanjana
    Krishnan, Gopala
    Hong, Ruey-Long
    Yang, Muh-Hwa
    Wang, Cheng-Hsu
    Sze, Wing-Kin
    Ng, Wai-Tong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (09): : 1225 - 1230
  • [2] PHASE II TRIAL OF FIRST-LINE CAPECITABINE PLUS OXALIPLATIN IN PATIENTS WITH METASTATIC NASOPHARYNGEAL CARCINOMA
    Chua, D.
    Ng, W. T.
    Ng, W. Y.
    Lui, C. Y.
    Li, V.
    Cheng, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 324 - 324
  • [3] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [4] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer
    Kim, TW
    Chang, HM
    Kang, HJ
    Lee, JR
    Ryu, MH
    Ahn, JH
    Kim, JH
    Lee, JS
    Kang, YK
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1115 - 1120
  • [5] Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer
    Cartwright, Thomas
    Kuefler, Paul
    Cohn, Allen
    Hyman, William
    Berger, Maury
    Richards, Donald
    Vukelja, Svetislava
    Nugent, John E.
    Ruxer, Robert L., Jr.
    Boehm, Kristi A.
    Asmar, Lina
    CLINICAL COLORECTAL CANCER, 2008, 7 (06) : 390 - 397
  • [6] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Li, Yu-Hong
    Wang, Feng-Hua
    Jiang, Wen-Qi
    Xiang, Xiao-Juan
    Deng, Yan-Ming
    Hu, Guo-Qing
    Xu, De-Ming
    Chen, Yan
    Lin, Qing
    He, You-Jian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 539 - 544
  • [7] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Yu-Hong Li
    Feng-Hua Wang
    Wen-Qi Jiang
    Xiao-Juan Xiang
    Yan-Ming Deng
    Guo-Qing Hu
    De-Ming Xu
    Yan Chen
    Qing Lin
    You-Jian He
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 539 - 544
  • [8] Phase II trial of oxaliplatin plus capecitabine as first-line treatment in patients with advanced gastric cancer (AGC)
    Palumbo, R.
    Bernardo, A.
    Strada, M. R.
    Poggi, G.
    Teragni, C.
    Delmonte, A.
    Frascaroli, M.
    Jedrychowska, I
    Canto, A. M.
    Bernardo, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI52
  • [9] Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer
    Yang, Tingsong
    Shen, Xiaojun
    Tang, Xiaojun
    Wei, Guo
    Zhang, Hao
    Du, Chenghui
    Xue, Xuchao
    Ma, Liye
    Nie, Mingming
    Bi, Jianwei
    TUMORI, 2011, 97 (04) : 466 - 472
  • [10] Phase II study of capecitabine and cisplatin as first-line chemotherapy in patients with advanced esophageal cancer
    Hong, Yong S.
    Lee, Hyo R.
    Hwang, In G.
    Lee, Sang C.
    Lee, Jeeyun
    Park, Joon O.
    Park, Young S.
    Lim, Ho Y.
    Im, Young-Hyuck
    Kang, Won K.
    ANNALS OF ONCOLOGY, 2006, 17 : 314 - 314
12345